Imoto S, Wang K, Bi XW, Liu G, et al. Survival advantage of locoregional and systemic therapy in oligometastatic breast cancer: an international retrospective cohort study (OLIGO-BC1). Breast Cancer 2023 Jan 23. doi: 10.1007/s12282-023-01436.
PMID: 36689066